Biosimilars Could Cut Spending for Biologic Therapy in the U.S.

Increased market growth of biosimilars that are similar to brand - name biologic agents has the potential to reduce spending on prescription drugs
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Endocrinology, Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Oncology, Ophthalmology, Pharmacy, Rheumatology, Journal, Source Type: news